Unanswered Questions: China's New Pharma Advertising Rule

Law360, New York (August 26, 2015, 10:11 AM EDT) -- This year, China’s advertising law[1] sees its first amendment in two decades. The amendment, which will be implemented as of Sept. 1, 2015, reflects the central government’s efforts to strengthen consumer protection and crack down on fraudulent marketing behaviors. It also specifically subjects life sciences companies to new advertising requirements and restrictions, reflecting that fraud and misstatements in drug and device advertising are rampant and have generated growing public concerns.

Echoing the amendment of the advertising law, the State Administration for Industry and Commerce (SAIC), the enforcement body overseeing advertising compliance, recently called for public comments on the follow-on revision of...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!